INR 6954.5
(-0.32%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 24.02 Billion INR | 14.02% |
2022 | 21.39 Billion INR | -4.37% |
2021 | 25.56 Billion INR | 93.53% |
2020 | 12.42 Billion INR | -26.65% |
2019 | 18.11 Billion INR | 41.28% |
2018 | 10.94 Billion INR | 34.06% |
2017 | 8.24 Billion INR | 5.3% |
2016 | 7.64 Billion INR | -4.65% |
2015 | 7.6 Billion INR | 8.9% |
2014 | 7.38 Billion INR | 10.01% |
2013 | 6.78 Billion INR | 7.55% |
2012 | 6.3 Billion INR | 16.3% |
2011 | 5.42 Billion INR | 24.08% |
2010 | 4.33 Billion INR | 30.2% |
2009 | 3.32 Billion INR | 36.66% |
2008 | 2.43 Billion INR | 17.22% |
2007 | 2.08 Billion INR | 26.43% |
2006 | 1.65 Billion INR | 24.26% |
2005 | 1.29 Billion INR | 12.38% |
2004 | 1.18 Billion INR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 6.75 Billion INR | 6.54% |
2023 FY | - INR | 14.02% |
2023 Q1 | 5.43 Billion INR | 6.89% |
2023 Q2 | 6.51 Billion INR | 20.01% |
2023 Q3 | 6.42 Billion INR | -1.37% |
2023 Q4 | 6.4 Billion INR | -0.37% |
2022 Q1 | 4.94 Billion INR | 18.07% |
2022 Q2 | 5.74 Billion INR | 16.17% |
2022 Q3 | 5.19 Billion INR | -9.68% |
2022 FY | - INR | -4.37% |
2022 Q4 | 5.08 Billion INR | -2.14% |
2021 FY | - INR | 93.53% |
2021 Q4 | 4.19 Billion INR | -31.31% |
2021 Q2 | 6.23 Billion INR | 15.32% |
2021 Q3 | 6.1 Billion INR | -2.09% |
2021 Q1 | 5.4 Billion INR | 35.35% |
2020 Q1 | 205.7 Million INR | -93.53% |
2020 FY | - INR | -26.65% |
2020 Q4 | 3.99 Billion INR | -2.94% |
2020 Q3 | 4.11 Billion INR | 36.24% |
2020 Q2 | 3.01 Billion INR | 1367.72% |
2019 Q4 | 3.17 Billion INR | -27.74% |
2019 FY | - INR | 41.28% |
2019 Q2 | 4.22 Billion INR | 16.01% |
2019 Q1 | 3.64 Billion INR | 21.6% |
2019 Q3 | 4.4 Billion INR | 4.15% |
2018 Q4 | 2.99 Billion INR | 4.77% |
2018 Q1 | 2.33 Billion INR | 0.0% |
2018 FY | - INR | 34.06% |
2018 Q2 | 2.74 Billion INR | 17.13% |
2018 Q3 | 2.85 Billion INR | 4.32% |
2017 FY | - INR | 5.3% |
2016 FY | - INR | -4.65% |
2015 FY | - INR | 8.9% |
2014 FY | - INR | 10.01% |
2013 FY | - INR | 7.55% |
2012 FY | - INR | 16.3% |
2011 FY | - INR | 24.08% |
2010 FY | - INR | 30.2% |
2009 FY | - INR | 36.66% |
2008 FY | - INR | 17.22% |
2007 FY | - INR | 26.43% |
2006 FY | - INR | 24.26% |
2005 FY | - INR | 12.38% |
2004 FY | - INR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Artemis Medicare Services Limited | 1.24 Billion INR | -1827.837% |
Aster DM Healthcare Limited | 6.11 Billion INR | -292.76% |
Fortis Healthcare Limited | 13.07 Billion INR | -83.716% |
HealthCare Global Enterprises Limited | 3.5 Billion INR | -585.438% |
Indraprastha Medical Corporation Limited | 2.1 Billion INR | -1042.449% |
Krishna Institute of Medical Sciences Limited | 6.61 Billion INR | -263.372% |
Lotus Eye Hospital and Institute Limited | 79.42 Million INR | -30142.748% |
Max Healthcare Institute Limited | 16.7 Billion INR | -43.816% |
Max India Limited | -353.8 Million INR | 6889.108% |
Global Health Limited | 8.71 Billion INR | -175.517% |
Narayana Hrudayalaya Limited | 12.42 Billion INR | -93.316% |
Rainbow Children's Medicare Limited | 4.69 Billion INR | -411.69% |
Shalby Limited | 1.98 Billion INR | -1112.825% |